Fibrin immunotherapy may resolve blood clotting
#1

Tenacious and life-threatening thrombotic events are one of the hallmarks of COVID-19, as aberrant blood clots can form in various organs and result in substantial morbidity and mortality. A triad of inflammation, disease severity, and hypercoagulable state are found underneath such clotting complications.

Conversely, even young COVID-19 patients with milder symptoms can be affected by pulmonary embolism, stroke, and sudden death. In addition, persistent clotting pathology is even characteristic of so-called “long-COVID.”


https://www.news-medical.net/news/202110...CoV-2.aspx
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)